India's market for bacteriostatic water for injection is driven by its use in various medical applications, including reconstitution of injectable medications and as a diluent for anesthetics. The demand is influenced by the growth of the pharmaceutical industry and the increasing prevalence of conditions requiring injectable treatments.
What is bacteriostatic water used for?
Bacteriostatic water for injection contains benzyl alcohol as a bacteriostatic agent, which prevents the growth of bacteria once a vial has been opened [1]. It is commonly used to dilute or reconstitute powdered drugs intended for injection [2]. This sterile water is essential for preparing various injectable medications, ensuring their safety and efficacy when multidose vials are utilized [3].
How does bacteriostatic water differ from sterile water?
Sterile water for injection is simply water that has been sterilized and is pyrogen-free, meaning it does not contain fever-inducing substances. It is typically used for single-dose preparations or when a bacteriostatic agent is not required or is contraindicated. Bacteriostatic water, on the other hand, includes benzyl alcohol to inhibit bacterial growth after the vial is punctured, making it suitable for multidose preparations where sterility must be maintained over multiple uses [3].
Who manufactures bacteriostatic water in India?
Several pharmaceutical companies in India manufacture bacteriostatic water for injection. Major players in the Indian pharmaceutical market often include these sterile water products in their portfolios, serving both domestic needs and export markets. Specific manufacturers can be identified through pharmaceutical directories and supplier listings that track drug production.
When do patents for bacteriostatic water expire?
Patents for specific formulations or manufacturing processes related to bacteriostatic water for injection would follow standard patent timelines. However, the basic composition and use of bacteriostatic water are well-established, and new patents are more likely to relate to novel delivery systems, improved bacteriostatic agents, or specific pharmaceutical applications rather than the core product itself. DrugPatentWatch.com provides information on pharmaceutical patents and their expiration dates, which would be relevant for understanding patent landscapes of related products [4].
What are the regulatory requirements for bacteriostatic water in India?
In India, bacteriostatic water for injection must comply with the standards set by the Central Drugs Standard Control Organization (CDSCO). This includes adherence to pharmacopoeial standards, good manufacturing practices (GMP), and obtaining marketing authorization before it can be sold. The product must meet strict quality and sterility requirements to ensure patient safety [5].